Coronary Heart Disease and Depression: The Next Steps

Frasure-Smith N Lespérance F. Recent evidence linking coronary heart disease and depression. Can J Psychiatry 2006;51:730–7.

ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. JAMA 2003;289:3106–16.

Skala J Freedland KE Carney RM . Coronary heart disease and depression: A review of recent mechanistic research. Can J Psychiatry 2006;51:738–45.

Musselman DL Tomer A Manatunga AK Knight BT Porter MR Kasey S , and others. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313–7.

Nair GV Gurbel PA O'Connor CM Gattis WA Murugesan SR Serebruany VL . Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. Am J Cardiol 1999;84:321–3.

Delisi SM Konopka LM O'Connor L Crayton JW . Platelet cytosolic calcium responses to serotonin in depressed patients and controls: Relationship to symptomatology and medication. Biol Psychiatry 1998;43:327–34.

Serebruany VL Glassman AH Malinin AI Nemeroff CB Musselman DL van Zyl LT , and others. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after coronary events. Circulation 2003;108:939–44.

Carney RM Blumenthal JA Freedland KE Stein PK Howells WB Berkman LF , and others. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165:1486–91.

Lespérance F Frasure-Smith N Theroux P Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004;161:271–7.

Miller GE Freedland KE Duntley S Carney RM . Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol 2005;95:317–21.

Rajagopalan S Brook R Rubenfire M Pitt E Young E Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196–8, A7.

Sherwood A Hinderliter AL Watkins LL Waugh RA Blumenthal JA . Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol 2005;46:656–9.

Maes M Smith R. Fatty acids, cytokines and major depression. Biol Psychiatry 1998;43:313–4.

Frasure-Smith N Lespérance F Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004;55:891–6.

Veith RC Lewis N Linares OA Barnes RF Raskind MA Villacres EC , and others. Sympathetic nervous system activity in major depression—basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1993;50:1–12.

Glassman AH Roose SP Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients: Risk-benefit reconsidered. JAMA 1993;269:2673–5.

Serebruany VL O'Connor CM Gurbel PA . Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am J Cardiol 2001;87:1398–400.

Lara N Archer SL Baker GB Le Melledo JM . Paroxetine-induced increase in metabolic end products of nitric oxide. J Clin Psychopharmacol 2003;23:641–5.

Glassman AH O'Connor CM Califf R Swedberg K Schwartz P Bigger JT Jr , and others. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701–9.

Brustolim D Ribeiro-Dos-Santos R Kast RE Altschuler EL Soares MB . A new chapter opens in anti-inflammatory treatments: The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 2006;6:903–7.

Abdel-Salam OM Baiuomy AR Arbid MS . Studies on the anti-inflammatory effect of fluoxetine in the rat. Pharmacol Res 2004;49:119–31.

O'Brien SM Scott LV Dinan TG . Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 2006;188:449–52.

Madsen T Christensen JH Blom M Schmidt EB . The effect of dietary n-3 acids on serum concentrations of C-reactive protein: A dose-response study. Br J Nutrition 2003;89:517–22.

Christensen JH Gustenhoff P Korup E Aaroe J Toft E Moller J , and others. Effect of fish oil on heart rate variability in survivors of myocardial infarction: A double blind randomised controlled trial. BMJ 1996;312:677–8.

Simopoulos AF . Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495–505.

Kasapis C Thompson PD . The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. J Am Coll Cardiol 2005;45:1563–9.

Blumenthal JA Babyak MA Carney RM Huber M Saab PG Burg MM , and others. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 2004;36:746–55.

Perini R Orizio C Baselli G Cerutti S Veicsteinas A. The influence of exercise intensity on the power spectrum of heart rate variability. Eur J Appl Physiol 1990;61:143–8.

Kemi OJ Haram PM Loennechen JP Osnes JB Skomedal T Wisloff U , and others. Moderate vs high exercise intensity: Differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function. Cardiovasc Res 2005;67:161–72.

Walser B Giordano RM Stebbins CL . Supplementation with omega-3 polyunsaturated fatty acids augments brachial artery dilation and blood flow during forearm contraction. Eur J Appl Physiol 2006;97:347–54.

Holguin F Tellez-Rojo MM Lazo M Mannino D Schwartz J Hernandez M , and others. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 2005;127:1102–7.

Tyring S Gottlieb A Papp K Gordon K Leonardi C Wang A , and others. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29–35.